Versartis amends IPO

Versartis Inc. (Redwood City, Calif.) amended its IPO on NASDAQ to include the number of shares and a price range. Versartis plans to sell 4.6 million shares at $16-$19. At the $17.50 midpoint, the company would raise $80.5 million and be valued at $382.5 million. Morgan Stanley; Citigroup; Cowen; and Canaccord are underwriters. Last month, Versartis raised $55 million in a series E round and filed to raise up to $80 million in the IPO (see BioCentury Extra, Feb. 18). ...